![](https://ml.globenewswire.com/media/b5f3e442-f2d8-4ccc-a040-d4d97405f7c4/small/neurometrix-rgb-jpg.jpg)
NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy
WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets, today announced important updates to its Quell® 2.0 …